TXG - 10x Genomics, Inc. -  [ ]

Ticker Details
10x Genomics, Inc.
IPO Date: September 12, 2019
Sector: Healthcare
Industry: Health Information Services
Market Cap: $2.94B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.72 | 2.79%
Avg Daily Range (30 D): $0.65 | 3.30%
Avg Daily Range (90 D): $0.56 | 2.91%
Institutional Daily Volume
Avg Daily Volume: 1.24M
Avg Daily Volume (30 D): 1.87M
Avg Daily Volume (90 D): 1.91M
Trade Size
Avg Trade Size (Sh.): 65
Avg Trade Size (Sh.) (30 D): 58
Avg Trade Size (Sh.) (90 D): 61
Institutional Trades
Total Institutional Trades: 4,862
Avg Institutional Trade: $3.81M
Avg Institutional Trade (30 D): $4.32M
Avg Institutional Trade (90 D): $3.72M
Avg Institutional Trade Volume: .09M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $6.88M
Avg Closing Trade (30 D): $7.85M
Avg Closing Trade (90 D): $7.13M
Avg Closing Volume: 166.47K
 
News
Apr 10, 2026 @ 9:45 AM
Global Next-Generation Sequencing (NGS) Market to ...
Source: Researchandmarkets.Com
Mar 23, 2026 @ 11:07 AM
These Are the Only 3 Stocks That Cathie Wood Bough...
Source: Rick Munarriz
Jan 20, 2026 @ 5:05 AM
Cathie Wood's Ark Unleashes Cryptic ARKmoji Teaser...
Source: Vishaal Sanjay
Dec 1, 2025 @ 3:00 PM
Tumor Transcriptomics Research Report 2025: An $8....
Source: Researchandmarkets.Com
Oct 24, 2025 @ 4:25 PM
Lancaster Opens $7 Million Position in 10x Genomic...
Source: Emma Newbery
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-.35 $-.13 $-.35
Diluted EPS $-.35 $-.13 $-.35
Revenue $642.82M $166.03M $642.82M
Gross Profit $443.88M $113.05M $443.88M
Net Income / Loss $-43.54M $-16.25M $-43.54M
Operating Income / Loss $-60.99M $-19.54M $-60.99M
Cost of Revenue $198.94M $52.99M $198.94M
Net Cash Flow $129.9M $41.26M $129.9M
PE Ratio